Capricor Therapeutics Inc

NASDAQ:CAPR   4:00:00 PM EDT
4.19
-0.09 (-2.10%)
5:05:19 PM EDT: $4.19 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)105.82M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1 Million
Adjusted EPS-$0.32
See more estimates
10-Day MA$4.42
50-Day MA$4.37
200-Day MA$4.69
See more pivots

Capricor Therapeutics Inc Stock, NASDAQ:CAPR

10865 Road to the Cure, Suite 150, San Diego, California 90211
United States of America
Phone: +1.310.358.3200
Number of Employees: 74

Description

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.